Company
Insybio
A disruptor to Precision Medicine and Nutrition through biomarker discovery.
Also known as InSyBio Ltd
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- InSyBio Ltd
Claim, correct or request removal
Record updated 29 September 2026
About
is a privately held Company focusing, through advanced big-data computational tools, on biomarker discovery for Cancer, Neurodegenerative diseases and Nutrition.
Funding snapshot
- Total raised
- $550KSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $550K2018-04-23
Funding rounds
- Round, 2018
- $550K2018-04-23, SEC form D sold, 5 investors
Products
- Web
- InSyBio Suite
Loading relationship preview